Karl J. Dria

N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes

Cynthia A. Morgan, Bibek Parajuli, Cameron D. Buchman et al. · Chemico-Biological Interactions · 2014 · 133 citations

Medicinal Chemistry, Bioorganic Chemistry, Aldehyde Dehydrogenase +11

Discovery of a Novel Class of Covalent Inhibitor for Aldehyde Dehydrogenases

May Khanna, Che-Hong Chen, Ann C. Kimble-Hill et al. · Journal of Biological Chemistry · 2011 · 87 citations · Full text

Aldo-keto Reductase, Molecular Pharmacology, Medicinal Chemistry +18

Isolation of Bright Blue Light-Emitting CdSe Nanocrystals with 6.5 kDa Core in Gram Scale: High Photoluminescence Efficiency Controlled by Surface Ligand Chemistry

Sukanta Dolai, Praneeth Reddy Nimmala, Manik Mandal et al. · Chemistry of Materials · 2013 · 83 citations

Chemical Engineering, Photoluminescence, Engineering +14

Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes

Megan Stringer, Irushi Abeysekera, Jared Thomas et al. · Physiology & Behavior · 2017 · 57 citations · Full text

Down Syndrome, Ts65dn Model, Physiology +4

Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model

Megan Stringer, Irushi Abeysekera, Karl J. Dria et al. · Pharmacology Biochemistry and Behavior · 2015 · 42 citations

Down Syndrome, Neuropsychological Functioning, Neuropsychology +10